Laddar...

Reversal Agents: What We Have and What We Can Expect

Clinical trials in patients with atrial fibrillation have demonstrated that non-vitamin K antagonist oral anticoagulants [novel oral anticoagulants (NOACs)] are markedly safer than warfarin with respect to serious bleeding—especially intracranial hemorrhage, the most feared and devastating complicat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Innov Card Rhythm Manag
Huvudupphovsman: Ruff, Christian T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: MediaSphere Medical 2018
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252789/
https://ncbi.nlm.nih.gov/pubmed/32477806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.19102/icrm.2018.090403
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!